Disc Medicine, Inc.

Disc Medicine, Inc. Beats on EPS, Stock Up 1.73%

Disc Medicine, Inc. reported a narrower-than-expected loss per share, which led to a positive stock reaction, with shares rising by 1.73%. However, the lack of revenue data and management commentary leaves investors with limited insights into the company's performance and future direction. The surprise in EPS may indicate better cost management or operational efficiency.